Publications:

Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type-B receptor 4.

Molecular Oncology

Ma, Weina W; Zhu, Man M; Wang, Bo B; Gong, Zhengyan Z; Du, Xia X; Yang, Tianfeng T; Shi, Xianpeng X; Dai, Bingling B; Zhan, Yingzhuan Y; Zhang, Dongdong D; Ji, Yanhong Y; Wang, Yang Y; Li, Song S; Zhang, Yanmin Y

Publication Date: 2022-07

Variant appearance in text: TIE2: S13A

PubMed Link: 35689424

Variant Present in the following documents:

• MOL2-16-2747.pdf

View BVdb publication page

Angpt2/Tie2 autostimulatory loop controls tumorigenesis.

Embo Molecular Medicine

Karabid, Ninelia Minaskan NM; Wiedemann, Tobias T; Gulde, Sebastian S; Mohr, Hermine H; Segaran, Renu Chandra RC; Geppert, Julia J; Rohm, Maria M; Vitale, Giovanni G; Gaudenzi, Germano G; Dicitore, Alessandra A; Ankerst, Donna Pauler DP; Chen, Yiyao Y; Braren, Rickmer R; Kaissis, Georg G; Schilling, Franz F; Schillmaier, Mathias M; Eisenhofer, Graeme G; Herzig, Stephan S; Roncaroli, Federico F; Honegger, Jürgen B JB; Pellegata, Natalia S NS

Publication Date: 2022-05-09

Variant appearance in text: TIE2: S13A

PubMed Link: 35266635

Variant Present in the following documents:

• EMMM-14-e14364.pdf

View BVdb publication page